GeneDx Reports Strong Q1 2025 Earnings with Revenue Exceeding $87 Million
GeneDx reported first-quarter revenue of over $87 million, surpassing expectations and marking the company's third consecutive quarter of profitability. The CEO highlighted a strategic shift toward proactive genetic disease diagnosis using whole exome and genome sequencing to improve patient outcomes and reduce healthcare costs.
Tickers: $WGS
Topics: financial performance genomics healthcare diagnostics